Pure Green Pharmaceuticals Report issue

For profit Phase 2

Organization Overview

First Clinical Trial
2020
NCT04679545
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pure Green Pharmaceuticals